Rapamycin protects cardiomyocytes against anoxia/reoxygenation injury by inducing autophagy through the PI3k/Akt pathway

Lu-qiao Wang , Xiao-shu Cheng , Cha-hua Huang , Bo Huang , Qian Liang

Current Medical Science ›› 2015, Vol. 35 ›› Issue (1) : 10 -15.

PDF
Current Medical Science ›› 2015, Vol. 35 ›› Issue (1) : 10 -15. DOI: 10.1007/s11596-015-1381-x
Article

Rapamycin protects cardiomyocytes against anoxia/reoxygenation injury by inducing autophagy through the PI3k/Akt pathway

Author information +
History +
PDF

Abstract

The purpose of this study was to investigate the potential cardioprotection roles of Rapamycin in anoxia/reoxygenation (A/R) injury of cardiomyocytes through inducing autophagy, and the involvement of PI3k/Akt pathway. We employed simulated A/R of neonatal rat ventricular myocytes (NRVM) as an in vitro model of ischemial/reperfusion (I/R) injury to the heart. NRVM were pretreated with four different concentrations of Rapamycin (20, 50, 100, 150 μmol/L), and pretreated with 10 mmol/L 3-methyladenine (3MA) for inhibiting autophagy during A/R. Then, Western blot analysis was used to examine variation in the expression of LC3-II, LC3-I, Bim, caspase-3, p-PI3KI, PI3KI, p-Akt and Akt. In our model, Rapamycin had a preferential action on autophagy, increasing the expression of LC3-II/LC3-I, whereas decreasing the expression of Bim and caspase-3. Moreover, our results also demonstrated that Rapamycin inhibited the activation of p-PI3KI and enhanced the activation of p-Akt. It is concluded that Rapamycin has a cardioprotection effect by inducing autophagy in a concentration-dependent manner against apopotosis through PI3K/Akt signaling pathway during A/R in NRVM.

Keywords

rapamycin / autophagy / anoxia/reoxygenation / apoptosis

Cite this article

Download citation ▾
Lu-qiao Wang, Xiao-shu Cheng, Cha-hua Huang, Bo Huang, Qian Liang. Rapamycin protects cardiomyocytes against anoxia/reoxygenation injury by inducing autophagy through the PI3k/Akt pathway. Current Medical Science, 2015, 35(1): 10-15 DOI:10.1007/s11596-015-1381-x

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

MurrayCJ, LopezAD. Alternate projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet, 1997, 349(9064): 1498-1504 PMID: 9167458

[2]

GottliebRA, MentzerRJ. Autophagy: an affair of the heart. Heart Fail Rev, 2013, 18(5): 575-584 PMCID: 3782636 PMID: 23188163

[3]

SabeAA, ElmadhunNY, DalalRS, et al. . Resveratrol regulates autophagy signaling in chronically ischemic myocardium. J Thorac Cardiovasc Surg, 2014, 147(2): 792-798 PMCID: 3947125 PMID: 24267781

[4]

ChoiAM, RyterSW, LevineB. Autophagy in human health and disease. N Engl J Med, 2013, 368(7): 1845-1846 PMID: 23656658

[5]

MatsuiY, TakagiH, QuX, et al. . Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res, 2007, 100(6): 914-922 PMID: 17332429

[6]

TakagiH, MatsuiY, SadoshimaJ. The role of autophagy in mediating cell survival and death during ischemia and reperfusion in the heart. Antioxid Redox Signal, 2007, 9(9): 1373-1381 PMID: 17627477

[7]

KhanS, SalloumF, DasA, et al. . Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes. J Mol Cell Cardiol, 2006, 41(2): 256-264 PMID: 16769083

[8]

RavikumarB, VacherC, BergerZ, et al. . Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet, 2004, 36(6): 585-595 PMID: 15146184

[9]

YouleRJ, StrasserA. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol, 2008, 9(1): 47-59 PMID: 18097445

[10]

YangSS, LiuYB, YuJB, et al. . Rapamycin protects heart from ischemia/reperfusion injury independent of autophagy by activating PI3 kinase-Akt pathway and mitochondria K (ATP) channel. Pharmazie, 2010, 65(10): 760-765 PMID: 21105579

[11]

WangX, DaiY, DingZ, et al. . Regulation of autophagy and apoptosis in response to angiotensin II in HL-1 cardiomyocytes. Biochem Biophys Res Commun, 2013, 440(4): 696-700 PMID: 24099770

[12]

CrowMT, ManiK, NamYJ, et al. . The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res, 2004, 95(10): 957-970 PMID: 15539639

[13]

DesagherS, MartinouJC. Mitochondria as the central control point of apoptosis. Trends Cell Biol, 2000, 10(9): 369-377 PMID: 10932094

[14]

Hamacher-BradyA, BradyNR, GottliebRA. Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem, 2006, 281(40): 29776-29787 PMID: 16882669

[15]

StennickeHR, SalvesenGS. Caspases-controlling intra-cellular signals by protease zymogen activation. Biochim Biophys Acta, 2000, 1477(1): 299-306 PMID: 10708865

[16]

RaphaelJ, ZuoZ, AbedatS, et al. . Isoflurane preconditioning decreases myocardial infarction in rabbits via up-regulation of hypoxia inducible factor 1 that is mediated by mammalian target of rapamycin. Anesthesiology, 2008, 108(3): 415-425 PMID: 18292679

[17]

TsangA, HausenloyDJ, MocanuMM, et al. . Postconditioning: a form of “modified reperfusion” protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res, 2004, 95(3): 230-232 PMID: 15242972

AI Summary AI Mindmap
PDF

87

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/